Skip to main content

Agilent Technologies Life Sciences and Diagnostics Markets revenue

  • A · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$173.96+0.55%Close 13 Nov 2026 · Market value $48.66B · Next results 23 Nov 2026

Life Sciences and Diagnostics Markets revenue at Agilent Technologies came to $746.0M for the quarter to 31 Jul 2026, up 11.3% from a year earlier.

As Agilent Technologies reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 1 Sep 2026.

By quarter

$620.0MJan 2024$604.0MApr 2024$585.0MJul 2024$657.0MOct 2024$647.0MJan 2025$654.0MApr 2025$670.0MJul 2025$755.0MOct 2025$679.0MJan 2026$732.0MApr 2026$746.0MJul 2026
Agilent Technologies Life Sciences and Diagnostics Markets revenue, every reported period
Period endingLife Sciences and Diagnostics Markets revenueChange on a yearFiled
31 Jul 2026$746.0Mup 11.3%1 Sep 2026
30 Apr 2026$732.0Mup 11.9%1 Jun 2026
31 Jan 2026$679.0Mup 4.9%3 Mar 2026
31 Oct 2025$755.0Mup 14.9%22 Dec 2025
31 Jul 2025$670.0Mup 14.5%29 Aug 2025
30 Apr 2025$654.0Mup 8.3%2 Jun 2025
31 Jan 2025$647.0Mup 4.4%3 Mar 2025
31 Oct 2024$657.0M—20 Dec 2024
31 Jul 2024$585.0M—30 Aug 2024
30 Apr 2024$604.0M—3 Jun 2024
31 Jan 2024$620.0M—5 Mar 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Agilent Technologies: Product revenue · Non-Instrumentation and Other revenue · Instrumentation revenue · Services and Other revenue · Agilent CrossLab revenue · Applied Markets revenue · Rest Of World revenue · United States revenue · China revenue · Americas revenue · Asia Pacific revenue · Europe revenue · financial statements

Every KPI and segment of A, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.